ClinicalTrials.Veeva

Menu

Living Conditions of Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma in the Côte d'Or Region (LymphoVi)

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Completed

Conditions

Diffuse Large Cell Diffuse Lymphoma
Follicular Lymphoma

Treatments

Other: Collection of clinical data and treatments
Other: Questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT04859920
MAYNADIE 2020

Details and patient eligibility

About

The development of new diagnostic tools and targeted therapy have significantly improved the management of non-Hodgkin's malignant lymphomas and thus their long-term prognosis. However, in the study of improved patient management, survival is not the only measurable indicator and preservation of quality of life is an essential component. In addition, there is little existing data regarding the determinants of quality of life in patients with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) in the general population in France.

Enrollment

157 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with DLBCL or FL between January 1, 2010 and December 31, 2017,
  • Alive as of January 1, 2021,
  • Updated patient address.

Exclusion criteria

  • Other forms of Hematologic Malignancies at diagnosis,
  • Minors.
  • Person subject to legal protection (curatorship, guardianship)
  • Person subject to a judicial safeguard measure
  • Pregnant, parturient or breastfeeding woman
  • Adults incapable of giving consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems